http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b9442d370019d20db596b8980397390
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Reedijk |
| name | Michael Reedijk |
| given-name | Michael |
| organization-name | Department of Surgical Oncology, University Health Network, Ontario, Canada. michael.reedijk@uhn.on.ca Department of Surgical Oncology, University Health Network, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada 1Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada; Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A1, Canada Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada; Department of Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada Department of Medical Biophysics, University of Toronto, Toronto, ON M1C 1A4, Canada;; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada;; Department of Surgical Oncology, University Health Network, Toronto, ON M5G 2C4, Canada 1Programs in Developmental Biology and Cancer Research, The Hospital for Sick Children;; 2Department of Surgery, Mount Sinai Hospital; Departments of; 3Surgical Oncology, 1The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; 2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; 5Department of Surgical Oncology, University Health Network, Toronto, Ontario, Canada. Authors' Affiliations: 1Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada; 2Department of Urology, University of California at San Francisco, San Francisco, California; and 3Department of Surgical Oncology, Princess Margaret Hospital and 4Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada; Authors' Affiliations: 1Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada; 2Department of Urology, University of California at San Francisco, San Francisco, California; and 3Department of Surgical Oncology, Princess Margaret Hospital and 4Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada 1Campbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada.; 4Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; 5Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada; Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5G 1X5, Canada Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. michael.reedijk@uhn.ca. Program in Developmental Biology and Stem Cell Research, The Hospital for Sick Children, MaRS East Tower, Ontario M5G 1L7, Canada. Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada M5G 2M9;; Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada M5G 2M9;; Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9 Authors' Affiliations: 1Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, 2Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, 3Department of Laboratory Medicine and Pathobiology, University of Toronto, 4Microarray Core Facility, University Health Network, and 5Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; Authors' Affiliations: 1Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, 2Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, 3Department of Laboratory Medicine and Pathobiology, University of Toronto, 4Microarray Core Facility, University Health Network, and 5Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; Authors' Affiliations: 1Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, 2Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, 3Department of Laboratory Medicine and Pathobiology, University of Toronto, 4Microarray Core Facility, University Health Network, and 5Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada |
Incoming Links
Total number of triples: 57.